Elicera Therapeutics

3.34 SEK

+5.70%

Less than 1K followers

ELIC

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Elicera Therapeutics

P/B

Median 2021-2025

 
2019202020212022202320242025
Share price (SEK)--5.023.524.561.675.22
Shares19.819.819.819.819.835.148.5
Market cap--99.369.590.258.6253.4
Enterprise value--46.9----
EV/S--79.9----
EV/EBITDA--neg.----
EV/EBIT--neg.----
P/E--neg.neg.neg.neg.neg.
P/B--1.902.125.502.8210.85
P/S--169.2----
Dividend yield--0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio-81.3 %95.4 %70.8 %54.3 %75.4 %85.2 %
Gearing ratio-------